Key Takeaways
- Revenue nearly doubled in two years: Full-year total income grew 37.19% YoY to ₹256.92 crores, driven by a dual-engine strategy of institutional B2B and a brand-led distribution model now spanning 170+ distributors.
- H2 margin compression from external shocks: EBITDA margins fell from ~18% in H1 to ~11% for the full year, hit by a 10.5% forex move, raw cashew nut price spikes, and IPO expenses entering the P&L.
- A greenfield plant is the next growth leg: A second facility in Andhra Pradesh targets commercial production in Q3 FY27, taking total capacity to 70,000 MT by FY30 and adding ~₹475 crores in peak revenue.
- The brand pivot is insulating the business: The Royal Mewa brand grew 6.5x this year, a deliberate shift from pure B2B to capture retail margins and build long-term household equity.
- What to watch next quarter: Whether hedging contracts materialize to protect against the forex and shipping volatility that compressed H2 margins, and the pace of new plant capex deployment with ₹25 crores in POs still to be issued.
The Growth Engine: Dual Strategy & Capacity
- Dual-engine model: Revenue growth came from a high-volume institutional B2B foundation and a distribution-led model that expanded to over 170 distributors across 20+ states, capturing better margins in retail-facing segments.
- Technology drove revenue ahead of capacity: Revenue nearly doubled in two years while capacity increased only 40-50%, because a November 2023 tech upgrade improved kernel recovery ratios, lifted whole-grain recovery, stopped kernel contamination, and cut energy use.
- Existing facility still has room: The 18,000 MT plant operated at 86% utilization, and management expects another 20-22% increment from current levels before the new plant contributes.
- Revenue per kg jumped: Realization moved from ₹120 to ₹161 per kg, driven by the technology upgrade improving output quality and by movement in commodity prices.
- No exports yet, but planned: The company exported some cargoes in FY25 but did not export in FY26; it will look at export markets once the new facility is in place, with long-term ambitions to serve Europe, the US, the Middle East, and China.
Pulkit Jain: "We are not just building a factory. We are building a high-margin automated processing hub that will significantly lower our per unit conversion costs."
Margin Walk: The H2 Compression
- Forex was the primary hit: Currency moved nearly 10.5% from its April 2025 base, impacting raw material procurement since the company imports raw cashew nuts.
- RCN prices spiked late: Raw cashew nut prices moved up in the later part of the year, making H1 margins materially better than H2.
- IPO costs entered the P&L: IPO-related expenses also contributed to the margin decline from ~18% to ~11%.
- Mitigation is in motion: Hedging processes with banks have been initiated, and some cost is being passed to customers via higher sales prices and to suppliers via lower purchase prices, balancing gross profit.
- Risk remains unhedged for now: Management acknowledged India could see further currency devaluation and is still talking to banks and shipping lines for longer-term contracts, with no finalized timeline.
The New Plant: Timeline, Scale & Economics
- IPO proceeds are funding it: Of the ₹74.45 crores raised, ₹57 crores is earmarked for the Vizianagaram facility; ₹39.53 crores was already committed via purchase orders as of March-end.
- Timeline: Trial productions begin November or December FY27, with commercial production from Q3 FY27.
- Ramp-up path: Management expects ~15% capacity utilization in FY27 (one quarter of operations), 65-70% in FY28, and 85-90% by the following fiscal.
- Revenue potential: The extra capacity can generate ~₹475 crores at 85% utilization.
- Margin uplift expected but unquantified: Management expects scalability to improve margins by "a couple of percent" but declined to give an exact number.
- Order visibility is thin by design: Institutional customers provide visibility of only one to three months, so no specific order backlog was disclosed, though 78% repeat revenue and an inability to serve new customers were cited as demand signals.
Brand, Distribution & the Retail Pivot
- Royal Mewa grew 6.5x: The brand moved from a pure B2B model to a brand-led model, insulating Pajson from commodity price swings and building long-term equity with Indian households.
- Quick commerce entry is in the pipeline: The company is already talking to Blinkit and Zepto, with certain prerequisites being fulfilled for listing.
- Marketing spend will be selective: A marketing budget focused on social media and online channels is being set up, but management was explicit it will not compromise margins to increase brand visibility.
- India is the anchor: Management noted India consumes 30-35% of global cashew production, making it the primary focus over exports for now.
Aayush Jain: "By moving from a pure B2B model to a brand-led model, we are insulating Pajson from commodity price swings and building long-term equity with Indian households."
Supply Chain & Sourcing Moat
- Farm-gate sourcing across seven countries: The company sources directly at the farm gate through deep relationships with local buying agents across seven producing countries, a supply chain built to withstand disruptions.
- No clear margin edge by origin: Management declined to provide a specific margin differential between Indian and African raw cashew nuts, stating pricing depends on buying throughout the season from each region to average out the purchase price.
- Inventory normalized: The increase in inventory this year reflects a return to normal operating levels after last year's plant shutdown for expansion deliberately depleted stock.
- Receivables rose with institutional mix: Trade receivables increased because the focus on growing revenue with institutional customers involves more credit, unlike last year when the plant shutdown led to a sell-off and collection of receivables.
Aayush Jain: "We don't just buy from the market. We source at the farm gate. By maintaining deep relationships with local buying agents across seven producing countries, we have built a supply chain that does not break when the wind changes."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Existing facility growth | Additional 20-22% revenue increment from current levels | FY27 |
| New plant commercial production | Trial productions begin Nov/Dec; commercial production starts | Q3 FY27 |
| New plant capacity ramp | ~15% in FY27, 65-70% in FY28, 85-90% thereafter | FY27-FY29 |
| New plant peak revenue | ~₹475 crores at 85% utilization | At maturity (FY29) |
| Normalized EBITDA margin | 15-16% going forward | Ongoing |
| FY28 margin improvement | "A couple of percent" uplift from scalability | FY28 |
| Remaining capex deployment | ₹20-25 crores in POs to be issued | Q1 FY27 |
| Hedging contracts | Currency and shipping hedges being negotiated with banks and shipping lines | No fixed timeline |
Key Metrics
| Metric | FY26 |
|---|---|
| Total income | ₹256.92 cr, +37.19% YoY |
| H2 total income | ₹138.5 cr, +37.38% YoY |
| EBITDA growth | +24.98% YoY (full year) |
| H2 EBITDA growth | +18.7% YoY |
| PAT growth | +21.4% YoY (full year) |
| H2 PAT growth | +8.97% YoY |
| EBITDA margin | Double-digit for full year; H2 compressed by forex, RCN prices, shipping disruptions |
| Normalized EBITDA margin guidance | 15% to 16% |
| Net worth | ₹136.03 cr |
| Debt-to-equity ratio | 0.25 |
| Capacity utilization | 86% of 18,000 MT facility |
| Installed capacity | 18,000 MT (FY26), expanded from 12,000 MT in FY25 |
| Average kernel yield | 24.57% |
| Average realization (RCN processed) | ₹161.48 per kg (FY26), vs ₹160 per kg in FY25 |
| Kernel realization | ~₹660 per kg |
| Whole vs broken recovery ratio | 70:30 (70% wholes, 30% pieces) |
| Repeat revenue from existing customers | 78% |
| Royal Mewa brand growth | Over 6.5x this year |
| Raw material import share | 93% to 94% imported, 6% to 8% domestic Indian crop |
| IPO proceeds raised | ₹74.45 cr |
| IPO proceeds committed to greenfield expansion | ₹39.53 cr via purchase orders as of March end |
| Total capex for new facility | ~₹76 cr (excluding land, already acquired) |
| New capacity peak revenue potential | ~₹475 cr at 85% utilization |
| Existing facility revenue growth expectation | 20% to 22% increment from current levels |
| New plant trial production timeline | November or December FY27, commercial production from Q4 FY27 |
| New plant utilization target FY28 | 65% to 70% |
| Capacity expansion target by FY30 | 70,000 MT |
| Trade payables | ~40 days in current fiscal |
| Short-term borrowing rate | ~8.4% last year, down by 25 bps this year |
| Currency movement impact | ~10.5% depreciation from April 2025 base, affecting procurement costs |